Sarah Sybert is managing editor of GovCIO Media & Research. She rejoined the team in October 2024 after serving as a senior communications associate at McKesson Medical-Surgical, where she led editorial content for the business unit’s internal audience and supported content development for senior executives.
Sarah’s history with GovCIO Media & Research began in 2021, when she served as a staff writer and researcher and then senior researcher. During that time, she covered the latest health and technology developments at the Department of Veterans Affairs. Previously, she was a staff writer and speaker researcher for Executive Mosaic, where she reported on government contracting news and trends.
She earned her bachelor’s degree in English literature with minors in creative writing and film studies from Flagler College. In her free time, you can find Sarah on the kickball field captaining a team of 24 overly competitive adults, playing new musical instruments or exploring her hometown of Richmond, Virginia, with friends.
As agencies modernize their IT infrastructure to remain competitive in the digital ecosystem, leaders are spearheading change management to ensure their workforce is up to speed.
As government works to integrate innovative technologies that expedite speed and effectiveness of its services, federal leaders are focusing on upskilling, training and hiring to continue to build upon these new opportunities.
The Office of the National Coordinator for Health Information Technology’s new United States Core Data for Interoperability version 2 (USCDI v2) tackles health disparities and better explains social determinants of health.
Since the beginning of the COVID-19 pandemic, the Department of Health and Human Services has been developing rapid, innovative solutions to support national response efforts.
The Food and Drug Administration is advising industry partners on new guidance for identifying and tracing prescription drugs as they move through the distribution supply chain to ensure availability of critical drugs during the pandemic, Leigh Verbois, director of FDA’s Office of Drug Security, Integrity and Response, told GovernmentCIO Media & Research.
Throughout the national COVID-19 response, government agencies have worked to expand access to care and address long-standing health equity challenges across the public health system.
As the cybersecurity threat landscape expands in the digital era, protecting medical data is becoming an increasing priority across the federal government.
Electronic discovery, or e-discovery, refers to a legal process of uncovering electronically stored information (ESI) for potential litigation purposes. As the amount of digital data continues to rise, e-discovery has the potential to transform the ways organizations collect, store and analyze information.
The agency is exploring how quantum computing could improve speed and efficiency of health and science applications to support long-term future demands.
The Food and Drug Administration is breaking down silos, spearheading new data sharing efforts and upskilling its workforce under its data strategy to turn data into a “strategic asset” and drive new efficiencies.
The Food and Drug Administration’s Center for Tobacco Products is leveraging emerging technologies to drive new efficiencies across its premarket review process, the center’s Office of Science Director Matt Holman said during an FDA meeting last week.
The COVID-19 pandemic has had varying impacts on tobacco and vaping use among youths and adults, but did not have any impact on users’ reported intention to quit, according to recent data from the Food and Drug Administration.
